Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Shares Issued (2019 - 2025)

Revolution Medicines (RVMD) has 7 years of Shares Issued data on record, last reported at -$4000.0 in Q4 2025.

  • For Q4 2025, Shares Issued changed N/A year-over-year to -$4000.0; the TTM value through Sep 2025 reached $4000.0, changed N/A, while the annual FY2023 figure was $323.7 million, 21757.26% up from the prior year.
  • Shares Issued reached -$4000.0 in Q4 2025 per RVMD's latest filing, down from $3000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $323.7 million in Q1 2023 and bottomed at -$280.9 million in Q2 2021.
  • Average Shares Issued over 5 years is $21.8 million, with a median of $6000.0 recorded in 2023.
  • The widest YoY moves for Shares Issued: up 1043266.67% in 2021, down 326724.42% in 2021.
  • A 5-year view of Shares Issued shows it stood at -$279.7 million in 2021, then surged by 100.28% to $777000.0 in 2022, then plummeted by 99.23% to $6000.0 in 2023, then crashed by 85933.33% to -$5.1 million in 2024, then skyrocketed by 99.92% to -$4000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$4000.0 in Q4 2025, $3000.0 in Q3 2025, and $1000.0 in Q1 2025.